Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Embrex - EMBX -- Ignore unavailable to you. Want to Upgrade?

To: Zeitgeist who wrote (36)	8/14/1998 9:09:00 AM
From: Toni Wheeler	Respond to of 59

Been too quiet here....I am happy with this report on 8/11: Embrex Second-Quarter Net Income Up 45% Due To Continued Revenue Growth PR Newswire - August 11, 1998 17:25 RESEARCH TRIANGLE PARK, N.C., Aug. 11 /PRNewswire/ -- Embrex, Inc. (Nasdaq: EMBX) today issued the following: Highlights * Record second-quarter net income of $605,000 versus $417,000 for sameperiod in 1997, a 45% increase * Record second-quarter revenues of $7.0 million, up 18% over secondquarter 1997 * Second-quarter 1998 EPS rises 40% to $0.07 from $0.05 in comparable1997 quarter * First half net income totaled $1.1 million, 67% more than net incomeof $679,000 for same period in 1997 What we need for this underfollowed company is just what Ms. Corliss was hired for--more PR and analyst coverage. IMO sm/mid caps are due to be "discovered" for their potential!! I agree with you, Z, and well put! ~T.